Genocea Biosciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €1.42M +20.8% -€13.31M -64.7% -939.7% +23 pp -€36.32M +7.7% -2,564.4% +3.1 pp
    €1.17M +∞% -€37.73M +12.2% -3,216.6% -32 pp -€33.72M +6.7% -2,874.6% -29 pp
    €0.00 +NaN% -€33.62M +40.1% N/A -€31.59M -10.7% N/A
    €0.00 +NaN% -€24.00M -51.0% N/A -€35.38M -11.7% N/A
    €0.00 -100.0% -€48.94M +14.4% N/A -€40.06M +18.1% N/A
    €202.81K -64.9% -€42.78M +16.7% -21,094.9% -150 pp -€33.91M +10.5% -16,722.1% -110 pp
    €578.23K +117.5% -€36.66M +20.4% -6,340.7% +51 pp -€30.70M +36.4% -5,309.3% +32 pp
    €265.82K -57.9% -€30.46M +69.6% -11,459.7% -86 pp -€22.51M +33.9% -8,468.8% -58 pp
    €630.88K -63.0% -€17.96M +55.7% -2,846.2% -22 pp -€16.82M +59.4% -2,665.4% -20 pp
    €1.71M +8.6% -€11.54M -9.0% -676.1% +1.3 pp -€10.55M -7.2% -618.2% +1.1 pp
    €1.57M -€12.67M -806.9% -€11.37M -723.6%

    Notifications